Sunshine Biopharma
Focus: Sunshine Biopharma is a Canadian pharmaceutical company headquartered in Quebec specializing in small-molecule drugs across cardiovascular, infectious disease, neurology, respiratory, and metabolic disease areas. The company operates primarily as a generic and ANDA manufacturer with a portfolio heavily concentrated in post-LOE products.
Profile data last refreshed 14h ago · AI intelligence enriched 1w ago
Open Jobs
0
About Sunshine Biopharma
AI assessmentNot HiringNo open roles listed right now. Follow Sunshine Biopharma to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Sunshine Biopharma's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
50 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$72M Part DStable
Post-LOE
Company's dominant revenue driver at 77% of total, representing atypical antipsychotic in a mature market with significant generic competition.
Help build intelligence for Sunshine Biopharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.